JP2013525490A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525490A5
JP2013525490A5 JP2013509201A JP2013509201A JP2013525490A5 JP 2013525490 A5 JP2013525490 A5 JP 2013525490A5 JP 2013509201 A JP2013509201 A JP 2013509201A JP 2013509201 A JP2013509201 A JP 2013509201A JP 2013525490 A5 JP2013525490 A5 JP 2013525490A5
Authority
JP
Japan
Prior art keywords
alkyl
hydroxyl
optionally substituted
halo
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013509201A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525490A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/035091 external-priority patent/WO2011140164A1/en
Publication of JP2013525490A publication Critical patent/JP2013525490A/ja
Publication of JP2013525490A5 publication Critical patent/JP2013525490A5/ja
Pending legal-status Critical Current

Links

JP2013509201A 2010-05-06 2011-05-04 Faahのモジュレータとして有用なアザインドール誘導体 Pending JP2013525490A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33197410P 2010-05-06 2010-05-06
US61/331,974 2010-05-06
PCT/US2011/035091 WO2011140164A1 (en) 2010-05-06 2011-05-04 Aza-indole derivatives useful as modulators of faah

Publications (2)

Publication Number Publication Date
JP2013525490A JP2013525490A (ja) 2013-06-20
JP2013525490A5 true JP2013525490A5 (enExample) 2014-06-05

Family

ID=44904047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013509201A Pending JP2013525490A (ja) 2010-05-06 2011-05-04 Faahのモジュレータとして有用なアザインドール誘導体

Country Status (8)

Country Link
US (1) US20130059850A1 (enExample)
EP (1) EP2566481A4 (enExample)
JP (1) JP2013525490A (enExample)
CN (1) CN102917707A (enExample)
AU (1) AU2011248175A1 (enExample)
BR (1) BR112012028055A2 (enExample)
CA (1) CA2797281A1 (enExample)
WO (1) WO2011140164A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201411236D0 (en) 2014-06-25 2014-08-06 Takeda Pharmaceutical Novel compounds
ES2885474T3 (es) 2015-10-13 2021-12-13 Inst Nat Sante Rech Med Derivados de sibirilina para la utilización en la prevención y/o tratamiento de trastornos asociados a la necroptosis celular
KR20190045216A (ko) * 2016-09-16 2019-05-02 수미토모 케미칼 컴퍼니 리미티드 복소환 화합물 및 그것을 함유하는 유해 절족 동물 방제제
CN109589325B (zh) * 2019-02-19 2019-11-26 牡丹江医学院 一种用于治疗肠炎的药物组合物及其制备方法
WO2020254289A1 (en) * 2019-06-17 2020-12-24 Ucb Pharma Gmbh N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as gpr17 modulators for treating cns disorders such as multiple sclerosis
CN111743864B (zh) * 2020-08-05 2022-04-01 牡丹江医学院 一种体育外伤喷雾剂及其制备方法
CN112159423A (zh) * 2020-11-03 2021-01-01 凯美克(上海)医药科技有限公司 1H-吡咯并[2,3-b]吡啶-2-硼酸频哪醇酯的合成方法
WO2022157392A1 (en) * 2021-01-25 2022-07-28 Seabelife Use of indole, 6- and 7-azaindole derivatives as inhibitors of ferroptosis regulated cell death

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH574441A5 (enExample) * 1973-06-14 1976-04-15 Ciba Geigy Ag
JPS5239672A (en) * 1975-09-26 1977-03-28 Sankyo Co Ltd Process for preparing indole-2-allyl-3- thioeter compounds
NZ222878A (en) * 1986-12-17 1991-02-26 Merck Frosst Canada Inc 3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
US5527819A (en) * 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
CN1119856A (zh) * 1993-02-24 1996-04-03 麦克公司 Hiv逆转录酶抑制剂
FR2705346B1 (fr) * 1993-05-18 1995-08-11 Union Pharma Scient Appl Nouveaux dérivés de pipéridinyl thio indole, leurs procédés de préparation, compositions pharmaceutiques les contenant, utiles notamment comme antalgiques .
RU2337909C2 (ru) * 2002-02-01 2008-11-10 Ф.Хоффманн-Ля Рош Аг Замещенные индолы и фармацевтическая композиция, обладающая агонистической активностью в отношении альфа-1a/l адренорецептора
UA78999C2 (en) * 2002-06-04 2007-05-10 Wyeth Corp 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
TW200403243A (en) * 2002-07-18 2004-03-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
US6800655B2 (en) * 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
WO2004074286A1 (en) * 2003-02-14 2004-09-02 Wyeth Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WO2006015123A1 (en) * 2004-07-27 2006-02-09 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
ATE445396T1 (de) * 2004-08-19 2009-10-15 Aventis Pharma Inc 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i
GB2422831A (en) * 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
UA95244C2 (ru) * 2005-06-22 2011-07-25 Плексикон, Инк. Соединения и способ модулирования активности киназ, и показания для их применения
US7960544B2 (en) * 2005-12-16 2011-06-14 Ironwood Pharmaceuticals, Inc. Useful indole compounds
US20090118503A1 (en) * 2007-06-20 2009-05-07 Kevin Sprott Faah inhibitors
BRPI0908851A2 (pt) * 2008-02-22 2017-05-30 Irm Llc compostos e composições como moduladores da atividades de gpr119
HUE025471T2 (hu) * 2008-04-16 2016-03-29 Karobio Ab Új ösztrogén receptor ligandumok

Similar Documents

Publication Publication Date Title
JP2013525490A5 (enExample)
JP2013525356A5 (enExample)
JP2011509309A5 (enExample)
JP2006502143A5 (enExample)
JP2015505296A5 (enExample)
JP2013520502A5 (enExample)
JP2009542613A5 (enExample)
JP2013523814A5 (enExample)
JP2014051526A5 (enExample)
JP2012041365A5 (enExample)
JP2014511892A5 (enExample)
JP2014508811A5 (enExample)
JP2013510120A5 (enExample)
JP2014507455A5 (enExample)
JP2013537203A5 (enExample)
JP2014513110A5 (enExample)
JP2013542261A5 (enExample)
JP2013505969A5 (enExample)
JP2016506962A5 (enExample)
JP2016040288A5 (enExample)
JP2013525458A5 (enExample)
JP2014509647A5 (enExample)
JP2013529196A5 (enExample)
JP2017517538A5 (enExample)
JP2016525135A5 (enExample)